Serge Elemans, a seasoned expert in the field of medical isotopes, brings a wealth of experience garnered over the past decade. A native of the Netherlands, Serge has held key roles at IDB Holland, Advanced Accelerator Applications (AAA), and Novartis.

In his most recent position at Novartis, he managed stakeholder relationships with reactor facilities worldwide, played a pivotal role in determining the location for a new medical isotope production facility in the United States, and provided strategic counsel to senior leadership within Novartis’s Radioligand Therapy platform and members of the Novartis executive committee. His advisory focused on medical isotopes and supply chain optimization.

Driven by a passion to share his deep expertise, Serge founded Nuclidx to support stakeholders across the global and rapidly evolving landscape of medical isotopes and nuclear medicine. Through Nuclidx, he aims to empower organizations with the insights and strategies needed to navigate this specialized and transformative sector.